Clinical trial
B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal…
NCT00488683 · Novartis Vaccines, Industry · Completed
Key facts
| NCT number | NCT00488683 |
|---|---|
| Title | B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants |
| Official title | A Phase II, Single Center, Open-label, Randomized Study to Investigate Meningococcal Serogroup A, C, W-135 and Y Saccharide Specific B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants |
| Lead sponsor | Novartis Vaccines, Industry |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Meningococcal Disease |
| Intervention type | Biological |
| Interventions | MenACWY-CRM, DTaP-Hib-IPV, PCV, MMR, Hib |
| Enrollment | 216 |
| Start date | Jul 1, 2007 |
| Primary completion | May 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Jun 20, 2007 |
| Last update posted | Oct 1, 2014 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: